Corbett Road Capital Management »

Halozyme Therapeutics shares owned by Corbett Road Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Corbett Road Capital Management from 13F filings

Historical chart of Corbett Road Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Corbett Road Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Corbett Road Capital Management

Quarter filed Position value Share count Share price at filing
2022-06-30 $727k 17k 43.99

More positions owned by Corbett Road Capital Management

Ishares Tr Short Treas Bd (SHV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard World Fds Inf Tech Etf (VGT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr S&p 100 Etf (OEF)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Quanta Services (PWR)
Nextera Energy (NEE)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Invesco Actively Managed Etf Total Return (GTO)
Hartford Fds Exchange Traded Total Rtrn Etf (HTRB)

View all positions for Corbett Road Capital Management

Top funds holding Halozyme Therapeutics

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Macquarie Group
Geode Capital Management
Jpmorgan Chase & Co
Congress Asset Management
Bank of America Corporation
Arrowpoint Asset Management
Handelsbanken Fonder AB
Invesco

View all funds holding Halozyme Therapeutics